Crossmark

A selective peptide inhibitor of Frizzled 7 receptors disrupts intestinal stem cells

Crossref DOI link: https://doi.org/10.1038/s41589-018-0035-2

Published Online: 2018-04-09

Published Print: 2018-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Nile, Aaron H.

de Sousa e Melo, Felipe

Mukund, Susmith

Piskol, Robert

Hansen, Simon

Zhou, Lijuan

Zhang, Yingnan

Fu, Yue

Gogol, Emily B.

Kömüves, László G.

Modrusan, Zora

Angers, Stephane http://orcid.org/0000-0001-7241-9044
Franke, Yvonne

Koth, Christopher

Fairbrother, Wayne J.

Wang, Weiru

de Sauvage, Frederic J.

Hannoush, Rami N.
License Information

Text and Data Mining valid from 2018-04-09
More Information

Article History

Received: 13 October 2017

Accepted: 21 February 2018

First Online: 9 April 2018

Change Date: 4 May 2018

Change Type: Correction

Change Details: The version of this article originally published contained older versions of the Life Sciences Reporting Summary and the Supplementary Text and Figures. The error has been corrected in the HTML and PDF versions of the article.

Competing interests

: The authors are employees of Genentech, a member of the Roche group. A patent (PCT/US2017/050841; A.H.N., Y.Z., L.Z., and R.N.H.) covering this work is pending.